Blood Cancer United Receives $8 Million Boost from Big Nova Foundation to Support Pediatric Research

In a bold move aimed at confronting the challenges faced by pediatric cancer research amid growing federal funding cuts, Blood Cancer United has announced a transformative gift of $8 million from the Big Nova Foundation. This significant contribution marks a new chapter for Blood Cancer United, previously known as The Leukemia & Lymphoma Society, as they prioritize research and support for children battling blood cancers.

As political climates shift and funding uncertainties loom, this donation is heralded as a crucial lifeline for young patients and their families. "Private philanthropy is the cavalry that ensures we do not lose an entire generation of researchers and clinical trials," emphasized E. Anders Kolb, M.D., President and CEO of Blood Cancer United. He credits the Big Nova Foundation's foresight in recognizing the urgent need to fortify the resources necessary for groundbreaking research.

The $8 million investment is earmarked for several key initiatives:

1. PedAL Master Clinical Trial: This funding will expedite the expansion of this global clinical trial, creating more connections for children to innovative and effective treatments while paving the way for future medical breakthroughs.
2. Innovative Research: Funds will also be directed toward cutting-edge research at all stages of discovery, aimed particularly at nurturing early-career scientists and accelerating pediatric-focused advancements in treatment.
3. Advocacy and Patient Support: This resource allocation will enhance advocacy efforts to secure federal research funding and ensure that patients receive essential care and services.

Sarah Asma, Executive Director of the Big Nova Foundation, expressed confidence in Blood Cancer United's capacity to navigate the rising challenges in pediatric cancer research. "They share our belief that protecting clinical and research trials is vital to preventing families from hearing the devastating words, 'We do not know how to save your child.' Any threat to research funding puts every child at risk," she stated.

Historically, the Moore family, who founded the Big Nova Foundation in 2023, has long been advocates for blood cancer research stemming from personal experiences with the illness. Their commitment to Blood Cancer United has been unwavering, with prior contributions exceeding $14 million towards its Dare to Dream Project, which aims to revolutionize the lives of those affected.

The establishment of the Big Nova Foundation represents a formalized approach to the Moore family's prolific philanthropic efforts, building upon their ongoing advocacy and community service in Central Florida and beyond for nearly a century.

In a world where funding for cancer research is under threat, this inspiring act of charity stands as a beacon of hope. It is a reminder that philanthropy can indeed be a catalyst for change, igniting a call for others in the community to contribute to Blood Cancer United’s mission, which is to pave the way for innovative treatments and ultimately, cancer cures.

More information about Blood Cancer United and its initiatives can be found on their official website or by reaching out to their dedicated support team. Their ongoing commitment is vital as they strive to decrease the impact of blood cancers on patients and their families and improve the quality of life for those affected.